詳細検索

詳細検索

お問い合わせ

Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Strategic SWOT Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends

Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Strategic SWOT Analysis - A Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPIs, and Recent Trends


Report Summary Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Co... もっと見る

 

 

出版社
Quaintel Research
クアインテルリサーチ
出版年月
2026年6月19日
電子版価格
納期
3-4営業日程度
ページ数
142
言語
英語

日本語のページはAI翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

Report Summary

Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Strategic SWOT Insights - A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, and Recent Trends Report is a comprehensive and easily accessible overview of Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.

The report begins with in-depth information about Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.

Next, the report assesses Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority)'s strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority)'s overall strategic standing and supports informed decision-making and strategic planning.

Finally, the report includes recent news and deal activities undertaken by Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) enhancing awareness of the company's business trends, growth perspectives, and more.

Key Highlights

Helse Sor-Ost RHF (South-Eastern Norway Regional Health Authority) is the largest of Norway’s four regional health authorities, established in 2007 under the ownership of the Norwegian Ministry of Health and Care Services. Headquartered in Hamar, Norway, the authority is responsible for providing specialized healthcare services to approximately 3.1 million residents across the regions of Innlandet, Buskerud, Akershus, Oslo, Vestfold, Ostfold, Telemark, and Agder. As a central pillar of Norway’s public healthcare system, Helse Sor-Ost RHF oversees a wide network of hospitals, psychiatric and substance abuse institutions, ambulance and emergency services, laboratory operations, patient transport, and hospital pharmacies. The organization operates through multiple health trusts and partners, ensuring high-quality, accessible, and equitable healthcare delivery. Guided by its vision, “Good and equal healthcare services for everyone who needs it, when they need it,” the authority upholds the values of quality, security, and respect. With a strong commitment to patient-centered care, innovation, and medical excellence, Helse Sor-Ost RHF plays a crucial role in maintaining Norway’s globally recognized, publicly funded healthcare system.

Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) in the News:-

2026-04-23 - Preventing Violence and Threats Against Hospital Staff
2026-04-22 - Will Better Handling of Birth Injuries
2026-04-14 - Best in the world at surviving childhood cancer
2026-04-04 - Forlenger avtalene innen rusbehandling
2026-03-25 - Now the work starts for a more uniform competence in AMKs and ambulance services


Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority)'s internal and external factors through SWOT analysis and Corporate Strategy.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority):

• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) PESTLE Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Value Chain Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Porter's Five Forces Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) VRIO Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) BCG Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Segmentation, Targeting and Positioning (STP) Analysis
• Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) Ansoff Matrix Analysis

ページTOPに戻る


Table of Contents

Tables 6
Charts 7
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Key Company Facts 8
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Company Description 9
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Top Executives 10
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Top Executives Biographies 11
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Head Office & Locations 13
Head Office - Country 13
Key Joint Ventures 14
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Products and Services 15
Products 15
Services 16
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Historic Events 17
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Company’s Mission and Vision 18
Mission 18
Vision 18
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Corporate Strategy 19
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Business Description 22
Hospital and Specialist Medical Services 22
Psychiatric and Substance Abuse Treatment Services 23
Emergency and Ambulance Services 24
Training, Education, and Research Institutions 24
Patient Transport and Logistics Services 25
Hospital Pharmacy and Laboratory Services 25
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - ESG Spotlight 26
Environment 26
Social 27
Corporate Governance 28
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - SWOT Analysis 29
Overview 29
Strengths 31
Weaknesses 33
Opportunities 35
Threats 38
Competing Players 40
Snapshot of Competing Players 41
Aleris Helse AS 41
Key Company Facts 41
Company Description 41
Diaverum AB 42
Key Company Facts 42
Company Description 42
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - In the News 43
23-Apr-2026- Preventing Violence and Threats Against Hospital Staff 43
22-Apr-2026- Will Better Handling of Birth Injuries 45
14-Apr-2026- Best in the world at surviving childhood cancer 46
04-Apr-2026- Forlenger avtalene innen rusbehandling 47
25-Mar-2026- Now the work starts for a more uniform competence in AMKs and ambulance services 48
25-Mar-2026- OUS has taken over a new treatment building for security psychiatry 50
20-Mar-2026- Health South-East increases efforts for circular solutions 50
17-Mar-2026- Ahus offers home rehabilitation after stroke 51
06-Mar-2026- Goal Setting for Regional Research Funds for 2027 52
05-Mar-2026- Strengthen patient safety and reduce double work 54
02-Mar-2026- Starter ny måling av pasienterfaringer i Helse Sor-Ost 55
25-Feb-2026- Norway at the Top of Europe in Cancer Survival 57
25-Feb-2026- Regional Development Plan for Helse Sor-Ost Revised 58
23-Feb-2026- Extending the Agreement Period for Private Rehabilitation Institutions 60
19-Feb-2026- Three out of Four are Satisfied with Hospitals 62
19-Feb-2026- Ruller ut tjeneste for timeavtale 63
13-Feb-2026- Status for procurement within rusbehandling 64
12-Feb-2026- Clear Signal for New Acute Building in Kristiansand 65
12-Feb-2026- Better Annual Result Than Budgeted 66
12-Feb-2026- Will Reach Cancer Package Goals 67
12-Feb-2026- New Governors in Health Enterprises 68
11-Feb-2026- Status for acquisition of rehabilitation services after treatment in the Stortinget 71
10-Feb-2026- References and Rejections for Private Rehabilitation 71
09-Feb-2026- Better Follow-up of Female Inmates 72
05-Feb-2026- Proposal for the Master Plan for Mjoss Hospital 73
02-Feb-2026- More time for patients with AI-assisted record keeping 75
26-Nov-2025- Won educational awards in Health South-East 77
25-Nov-2025- National boost in fetal monitoring 79
20-Nov-2025- Strengthens rehabilitation services in health trusts 80
20-Nov-2025- Better Offers for Patients with Cognitive Impairment 82
28-Oct-2025- Entering into new agreements within specialized rehabilitation 84
23-Oct-2025- Opening of New Hospital in Drammen 87
23-Oct-2025- Better Follow-up of Maintenance in Hospital Buildings 89
15-Oct-2025- New Building Projects in Helse Sor-Ost on the Government Budget 90
10-Oct-2025- Robots That Clean Up Waiting Lists 91
26-Sep-2025- Termination of Agreement with Medi3 Oslo 93
25-Sep-2025- Possible takeover of contractual responsibility for the deadline breach scheme 94
25-Sep-2025- Better Imaging Diagnostics for the Best of Patients 95
25-Sep-2025- Updating the Needs Assessment for Substance Abuse Treatment 97
15-Sep-2025- They Make Healthcare Even Better 98
04-Sep-2025- Agreement for Private Healthcare Services within Colonoscopy 99
01-Sep-2025- Sustainability Award for Our Pension Fund 100
28-Aug-2025- Prepared for Tougher Competition for Employees 101
28-Aug-2025- More Patients Receive Treatment 103
28-Aug-2025- More patients receive treatment 104
28-Aug-2025- Prepared for tougher competition for employees 105
27-Aug-2025- New rehabilitation agreements will be awarded at the end of October 106
26-Aug-2025- New acute drug treatment center opens at new Drammen Hospital 107
21-Aug-2025- MR is not always the best option 109
21-Aug-2025- Improves the quality of practical studies for nursing students 110
15-Jul-2025- Children should receive better coordinated health services 111
02-Apr-2025- South-Eastern Health RHF has appointed a group-wide data protection officer 112
31-Mar-2025- Significant increase in the number of LIS1 positions 113
24-Mar-2025- Want to reduce vision loss with AI solution 114
06-Mar-2025- Focus on health literacy and migration health 115
06-Mar-2025- Will provide young people with their own inpatient beds in security psychiatry 116
21-Feb-2025- Shorter processing time in New methods 117
11-Feb-2025- Introducing new treatment for patients with cluster headaches 117
06-Feb-2025- More young people receive mental health care 118
09-Jan-2025- More meetings at the agreed time 118
19-Dec-2024- NOK 149 million for new research projects in Health South-East 119
19-Dec-2024- Planning expansion at Kalnes and Ahus 120
05-Dec-2024- Allocation of NOK 172 million to national clinical treatment studies 121
30-Nov-2023- South-Eastern Norway Regional Health Authority's loan scheme saves energy and provides environmental benefits 121
22-Nov-2023- Moving forward with plans for new emergency building in Kristiansand 123
22-Nov-2023- Hospitals' needs lead the way for a new technology strategy 123
21-Nov-2023- Cancer patients receive follow-up at home 126
29-Sep-2023- Modernising property management in hospitals 127
29-Sep-2023- Will prioritise mental health care in the coming years 128
22-Sep-2023- Working together on new therapies 129
01-Sep-2023- Patients with chronic pain are offered further follow-up 131
29-Aug-2023- Approving cancer drugs for new areas 131
03-Aug-2023- South-Eastern Norway Regional Health Authority on top in use of home dialysis 133
Helse Sor-Ost RHF (South Eastern Norway Regional Health Authority) - Key Deals 136
03-Nov-2023 - Will enter into new agreements for treatment of eating disorders 136
30-Sep-2022 - New agreements on the purchase of health services from private companies – Health and work 137
Appendix 139
Definitions 139
SWOT Analysis 139
PESTLE Analysis 139
Value Chain Analysis 139
ESG Spotlight 139
Research Methodology 140
Disclaimer 141
Contact Us 141

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療/ヘルスケア)の最新刊レポート

Quaintel Research社の 医薬品・医療分野 での最新刊レポート

本レポートと同じKEY WORD(corporate)の最新刊レポート


よくあるご質問


Quaintel Research社はどのような調査会社ですか?


Quaintel Researchはインドを拠点をとする調査会社です。 様々な企業の分析を行っており、企業の競合分析に役立つ資料をご提供します。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/08/17 10:26

160.11 円

185.73 円

219.67 円

ページTOPに戻る